BioCatalyst

GLM101 (Part A, Double-blind), GLM101 (Part B, Open-label) — catalyst calendar

1 verified catalyst event(s) referencing GLM101 (Part A, Double-blind), GLM101 (Part B, Open-label), each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-30
in 2mo
ESTIMATED
 READOUT
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participa
Phase 2/3 · Phosphomannomutase 2 Deficiency, PMM2-CDG
 Glycomine, Inc. GLM101 (Part A, Double-blind), GLM101 (P ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.